Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2022 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 483.03M | 356.15M | 519.81M | 2.31B | 862.03M | 699.36M |
Gross Profit | 56.80M | 42.09M | 49.41M | 591.72M | 245.54M | 253.59M |
EBITDA | -464.89M | -498.04M | -492.25M | 435.61M | 101.36M | 86.39M |
Net Income | -894.09M | -472.65M | -483.27M | 274.14M | 25.14M | 12.34M |
Balance Sheet | ||||||
Total Assets | 0.00 | 2.58B | 3.52B | 4.25B | 3.99B | 3.84B |
Cash, Cash Equivalents and Short-Term Investments | 9.60M | 4.75M | 10.53M | 3.98M | 23.02M | 10.30M |
Total Debt | 0.00 | 402.00M | 390.67M | 324.57M | 410.29M | 181.51M |
Total Liabilities | -1.79B | 956.37M | 1.42B | 1.69B | 1.41B | 854.98M |
Stockholders Equity | 1.79B | 1.65B | 2.12B | 2.58B | 2.60B | 2.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -20.26M | 23.33M | -176.35M | -23.75M | -113.64M |
Operating Cash Flow | 0.00 | -20.26M | 23.72M | -173.56M | -19.95M | -54.41M |
Investing Cash Flow | 0.00 | 8.64M | 26.00M | -1.58M | -5.50M | -55.63M |
Financing Cash Flow | 0.00 | 5.87M | -33.71M | 35.88M | 20.59M | -63.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ₹118.71B | 91.46 | 0.10% | 59.90% | 49.33% | ||
58 Neutral | ₹976.55M | 98.19 | ― | -0.46% | ― | ||
57 Neutral | €1.69B | 12.24 | 1.59% | 3.67% | 2.96% | -106.86% | |
45 Neutral | ₹891.93M | ― | ― | -31.48% | 54.17% | ||
43 Neutral | ₹822.54M | ― | ― | -5.70% | -1665.16% |
Cerebra Integrated Technologies Limited has received a demand notice from Canara Bank under the SARFAESI Act, indicating financial obligations that need addressing. The company is currently assessing the notice and considering legal options, while ensuring compliance with SEBI regulations by keeping stakeholders informed of any significant developments.
Cerebra Integrated Technologies Limited announced the closure of its trading window in compliance with SEBI regulations, effective from July 1, 2025, until 48 hours after the release of its unaudited financial results for the first quarter ending June 30, 2025. This measure is intended to prevent insider trading by restricting company insiders, including employees and directors, from trading in the company’s securities during this period.